Unsere Forschungs- und Entwicklungsteams sind weltweit im Einsatz und generieren Synergien aus unserem Expertenwissen und verwandten Fachdisziplinen. Wir stehen im internationalen Austausch mit unabhängigen Fachinstitutionen, Key Opinion Leadern und Multiplikatoren, um so Kooperations- und Wissensmanagement auf höchstem Niveau gewährleisten zu können. Im Rahmen dessen führen wir umfangreiche Forschungen durch, die kontinuierlich auf Kongressen in Form von Postern oder freien Vorträgen unserer Kooperationspartner sowie in Symposien und Workshops präsentiert und in namhaften wissenschaftlichen Fachzeitschriften veröffentlicht werden. Die größtenteils von unabhängigen Gutachtern bewerteten, evidenzbasierten Fachpublikationen, stellen wir Ihnen in dieser Datenbank zur Verfügung:
-
Journal article
Praxisorientierte Expertenempfehlung zur Behandlung kritisch-kolonisierter und lokal infizierter Wunden mit Polihexanid
ZfW 2009 2026Products Suprasorb X + PHMBDownloads Citation (RIS) -
Journal article
Erfolgreiche MRSA-Dekontamination und Überwindung der Stagnation der Wundheilung eines Ulcus cruris venosum
Vasomed 2009 21(6)Products Suprasorb X + PHMBDownloads Citation (RIS) -
Journal article
Kasuistik: Erfolgreiche Sanierung eines MRSA-kontaminierten sakralen Dekubitus mit einem PHMB-haltigem Wundverband
Wund Management 2009 3(5) 150152Products Suprasorb X + PHMBDownloads Citation (RIS) -
Journal article
Development and implementation of a clinical pathway to improve venous leg ulcer treatment
Wounds : a compendium of clinical research and practice 2009 21(5) 127133 A clinical pathway (CP) was developed and implemented to improve treatment outcomes for patients with venous leg ulcers. The CP and products (Rosidal® sys, Suprasorb® A, Suprasorb® P, and Suprasorb® C, Lohmann & Rauscher GmbH, Rengsdorf, Germany) were tested by case evaluation. Patients from the center were examined to determine his or her general condition, associated factors, wound type and stage, wound evolution, quality of life (QOL), treatment efficacy, and costs. Patients with venous leg ulceration (N = 20) were recruited to the clinical evaluation. Examination was performed upon presentation, and then at 2-week intervals for 12 weeks. The patients were then followed until ulcer closure. The outcome of the study group (SG) was compared to the results of a randomly selected patient control group (CG) at the center before implementing the clinical pathway. Statistic evaluation was performed using StatXact 5.0, double sided (α = 0.05) for paired and Wilcoxon test, and unpaired with Mann-Whitney (N = 20, [10/10]). After implementation, a statistically significant (P < 0.005) shorter period for ulcer closure was demonstrated for the SG when compared to previous treatment given to the CG. In the SG, 5/10 ulcers closed within 12 weeks versus 3/10 in the CG. An improvement in QOL was noted for the SG (P < 0.05 for the combined parameters, and P < 0.005 for pain), as well as cost savings (P < 0.05). The CP applied throughout the complete care chain improved quality of treatment outcomes and made effective use of resources and materials.
PMID 25903321Downloads Citation (RIS) -
Journal article
Suprasorb X + PHMB: the clinical evidence
Journal of wound care 2009Products Suprasorb X + PHMBDownloads Citation (RIS) -
Journal article
PHMB: a well-tolerated antiseptic with no reported toxic effects
Journal of wound care 2009 914Products Suprasorb X + PHMBDownloads Citation (RIS) -
Journal article
Suprasorb® X +PHMB: antimicrobial and HydroBalance action in a new wound dressing
Wounds UK 2009 5(1) 7277Products Suprasorb X + PHMBDownloads Citation (RIS)Further versions -
Journal article
Chronic oedema in patients with CVI and ulceration of the lower limb
British journal of community nursing 2009 14(10) 468Patients with chronic venous insufficiency and ulceration can have additional problems with chronic oedema, if a combination of venous and lymphatic insufficiency is present. Standard leg ulcer bandaging systems may not be suitable for reducing chronic oedema. This article provides the opportunity for practitioners to learn more about oedema in patients with CVI and to reflect on their current bandaging practice.
Products MollelastPMID 19966695Downloads Citation (RIS) -
Journal article
NO RESISTANCE AFTER 100 DAYS REPEATED INCUBATION OF STAPHYLOCOCCUS AUREUS WITH POLJHEXANIDE
Wound Rep Reg 2009 17 84Products Suprasorb A + Ag, Suprasorb X + PHMBDownloads Citation (RIS)Further versions -
Journal article
Erfahrungsbericht mit einem neuen „Controlled Negative Pressure“-System*
Wund Management 2009 3(4) 160161Products Suprasorb FDownloads Citation (RIS)